Oncternal Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ONCT for the last quarter is 297.00 k USD, and it's 65.92% higher compared to the previous quarter. The net income of Q4 23 is -9.16 M USD.